Musaffa Logo
Sun Pharmaceutical Industries Ltd SUNPHARMA.NS

Last Updated: Jul 21, 12:00 AM·NSE

SUNPHARMA.NS Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Sun Pharmaceutical Industries Ltd is classified as halal.

HALAL

Report Source: 2026 Annual Report

Sun Pharmaceutical Industries Ltd

Sun Pharmaceutical Industries Ltd. Stock Analysis SUNPHARMA.NS

India Health Care Large Cap Report:
Sun Pharmaceutical Industries Ltd. engages in manufacturing, developing, and marketing of pharmaceuticals products. The company is headquartered in Mumbai, Maharashtra and currently employs 43,000 full-time employees. The firm's global specialty portfolio spans products in dermatology, ophthalmology, and onco-dermatologym, among others. The firm manufactures and markets a large basket of pharmaceutical formulations across chronic and acute therapies, including generic, branded generics, specialty and complex products, over-the-counter (OTC), antiretrovirals (ARV), Active Pharmaceutical Ingredients (API), and intermediates. Its portfolio spans multiple dosage forms, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids. Its marketed specialty portfolio includes Ilumya/ Ilumetri, Winlevi, Levulan Kerastick + BLU-U, Absorica LD, Odomzo, Cequa, Bromsite, Xelpros, and others. Its portfolio also includes UNLOXCYTTM, an anti-PD-L1 treatment for advanced cutaneous squamous cell carcinoma.
Read More

Sun Pharmaceutical Industries Ltd (SUNPHARMA.NS) Chart

Key Statistics of Sun Pharmaceutical Industries Ltd (SUNPHARMA.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹1,938.20₹1,966.50

Today's Open

₹1,952.10

Volume

1.41M

P/E Ratio (TTM)

40.40

52 Week Range

₹1,548.00₹1,966.50

Market Cap

4.57T

Avg. Volume

1.97M

Dividend Yield

0.85%

Financial Metrics & Statements of Sun Pharmaceutical Industries Ltd (SUNPHARMA.NS)

Super Investors Invested in Sun Pharmaceutical Industries Ltd (SUNPHARMA.NS)

FAQ's for Sun Pharmaceutical Industries Ltd (SUNPHARMA.NS)

  • As of July 2026, Sun Pharmaceutical Industries Ltd SUNPHARMA.NS is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Sun Pharmaceutical Industries Ltd using these criteria to determine its compliance status.
  • Muslim investors may consider investing in Sun Pharmaceutical Industries Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of Sun Pharmaceutical Industries Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of Sun Pharmaceutical Industries Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of Sun Pharmaceutical Industries Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.